Kubo Toshihide, Shimizu Junya, Furujo Mahoko, Takeuchi Akihito, Yoshioka-Iwaso Haruna, Eguchi Naohiko, Fukuhara Shinichi, Koyama Teruhisa, Kanadani Tomohisa, Shiraga Hiroshi, Oshima Koh-ichi
Department of Pediatrics, National Hospital Organization, Okayama Medical Center, Japan.
Endocr J. 2005 Oct;52(5):647-50. doi: 10.1507/endocrj.52.647.
Graves' disease is a rare disorder in children, particularly in infants. Ocular manifestations of Graves' disease in children are even more rare and are mild compared to adults. We report a 3-year-old girl with Graves' ophthalmopathy who visited our clinic because of lacrimation. Her family had also noticed exophthalmos, goiter, irritability and increased appetite for more than 3 months. The ophthalmologist noted bilateral proptosis, eyelid erythema, lacrimation, entropion of the lower eyelid, and superficial keratitis. Her serum concentrations of free thyroxine and free triiodothyronine were high, and thyroid-stimulating hormone (TSH) was low. Serum samples were markedly positive for antibodies to TSH receptor (TRAb) and thyroid-stimulating antibody (TSAb). Although hyperthyroidism was controlled with propylthiouracil within 3 weeks, her eye signs did not improve. We administered methylprednisolone pulse therapy for ophthalmopathy, but the effect was limited and the lacrimation due to entropion and superficial keratitis persisted. Titers of both TRAb and TSAb decreased slightly and transiently with the pulse therapy. One year later, both titers remained high and eye signs did not improve any more though she was clinically euthyroid. This might indicate that both TRAb and TSAb levels correlate with the clinical course. Therefore, TRAb or TSAb might be good indicators of progress of Graves' ophthalmopathy. Ocular manifestations of Graves' disease should be followed closely with measurements of both TRAb and TSAb even in infant cases.
格雷夫斯病在儿童中较为罕见,在婴儿中尤为如此。儿童格雷夫斯病的眼部表现更为罕见,且与成人相比症状较轻。我们报告了一名3岁患有格雷夫斯眼病的女孩,她因流泪前来我们诊所就诊。她的家人还注意到眼球突出、甲状腺肿大、易怒和食欲增加超过3个月。眼科医生检查发现双侧眼球突出、眼睑红斑、流泪、下睑内翻和浅层角膜炎。她的血清游离甲状腺素和游离三碘甲状腺原氨酸浓度升高,促甲状腺激素(TSH)降低。血清样本中促甲状腺激素受体抗体(TRAb)和促甲状腺刺激抗体(TSAb)呈明显阳性。尽管在3周内用丙硫氧嘧啶控制了甲状腺功能亢进,但她的眼部体征并未改善。我们对眼病进行了甲泼尼龙冲击治疗,但效果有限,因下睑内翻和浅层角膜炎导致的流泪症状持续存在。冲击治疗后TRAb和TSAb的滴度均有轻微且短暂的下降。一年后,尽管她临床甲状腺功能正常,但两种抗体滴度仍很高,眼部体征也没有进一步改善。这可能表明TRAb和TSAb水平与临床病程相关。因此,TRAb或TSAb可能是格雷夫斯眼病病情进展的良好指标。即使是婴儿病例,也应通过检测TRAb和TSAb密切跟踪格雷夫斯病的眼部表现。